F. Kermeen

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

Victor F. Tapson, Fernando Torres, F. Kermeen et al. · CHEST Journal · 2012 · 374 citations

Freedom-c Study, Hypertension, Pulmonary Arterial Hypertension +11

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

R. James White, Carlos Jerjes‐Sánchez, G. Meyer et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 142 citations · Full text

Time from Symptoms to Definitive Diagnosis of Idiopathic Pulmonary Arterial Hypertension: The Delay Study

Geoff Strange, Eli Gabbay, F. Kermeen et al. · Pulmonary Circulation · 2013 · 139 citations · Full text

Hypertension, Heart Failure, Pulmonary Care +21

Human Metapneumovirus in Lung Transplant Recipients and Comparison to Respiratory Syncytial Virus

Peter Hopkins, Keith McNeil, F. Kermeen et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 126 citations

Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion values

Marco van Kessel, David Seaton, Jonathan Chan et al. · International journal of cardiac imaging · 2016 · 62 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +11